In dissolution testing the release of API (active pharmaceutical ingredient) from tablets/capsules is tested. Often dissolution testing is an important parameter in the development of new medical products - DB Lab are very experienced in performing these tests and may be a valuable business partner when the dissolution profile of new formulations is tested. Dissolution is often part of the release testing and is also a central part of the tests during stability studies.

DB Lab has dissolution equipment with basket (Apparatus) og paddle (Apparatus 2). We perform dissolution testing on various types of dosage units:

”Conventional-release solid dosage forms” - tablets or capsules which are dissolved within one hour

”Prolonged-release solid dosage forms”, tablets or capsules which are dissolved over a longer period of time, e.g. within 8 or 24 hours

”Delayed-release solid dosage forms”, with change of media during the test. This test is usually performed with entero-coated tablets